+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Preclinical Imaging Market by Product, Application, End-User - Global Forecast 2025-2030- Product Image
Preclinical Imaging Market by Product, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Preclinical Imaging Market by Product, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968721
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Preclinical Imaging Market grew from USD 2.48 billion in 2023 to USD 2.60 billion in 2024. It is expected to continue growing at a CAGR of 4.91%, reaching USD 3.48 billion by 2030.

Preclinical imaging, a critical aspect of drug discovery and development, involves non-invasive imaging techniques used in research settings to study diseases, monitor therapeutic interventions, and evaluate biological processes in animal models. The necessity of preclinical imaging stems from the growing demand for precise and comprehensive data in biomedical research, which can significantly reduce the cost and time associated with drug development. Its applications span across oncology, neurology, cardiology, and infectious diseases, contributing to our understanding of disease mechanisms at a molecular level. End-use sectors primarily include pharmaceutical and biotechnology companies, research institutions, and contract research organizations (CROs). Market growth is driven by technological advancements in imaging modalities - such as micro-CT, PET/SPECT, and MRI - that provide enhanced image resolution and quantitative capabilities. Additionally, the rising prevalence of chronic diseases and the increase in research and development expenditure further fuel market expansion. However, the market faces limitations including the high cost of equipment, the need for specialized skills to operate complex imaging systems, and ethical concerns regarding animal testing. Opportunities in this space lie in the integration of AI and machine learning with imaging systems to enhance data analysis and decision-making processes, thus increasing efficiency. Innovations in multimodal imaging and image processing offer the potential for more accurate and comprehensive insights into disease pathways, presenting significant business growth opportunities. However, navigating regulatory protocols and the ongoing requirement for high initial investment remain challenging. Companies can benefit by focusing on personalized medicine and the development of imaging agents that target specific disease markers, thus catering to the growing demand for precision medicine. The market is characterized by rapid technological advancements, competitive pressures, and the evolving nature of healthcare needs, necessitating agile strategies to maintain a competitive edge.

Understanding Market Dynamics in the Preclinical Imaging Market

The Preclinical Imaging Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing research & development activities by pharmaceutical companies
    • Growing government investment and funding for expanding biomedical research
    • Rising number of clinical research organizations (CROs)
  • Market Restraints
    • High cost of imaging equipment and maintenance of preclinical imaging
  • Market Opportunities
    • Increasing incorporation of advanced technologies in preclinical imaging to improve image analysis
    • Rising focus on the development of personalized medicines
  • Market Challenges
    • Strict regulations and ethical concerns associated with animal research

Exploring Porter’s Five Forces for the Preclinical Imaging Market

Porter’s Five Forces framework further strengthens the insights of the Preclinical Imaging Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Preclinical Imaging Market

External macro-environmental factors deeply influence the performance of the Preclinical Imaging Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Preclinical Imaging Market

The Preclinical Imaging Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Preclinical Imaging Market

The Preclinical Imaging Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Preclinical Imaging Market

The Preclinical Imaging Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Advanced Molecular Vision, Inc., Angstrom Advanced Inc., Aspect Imaging Ltd., Berthold Technologies, Bruker Corporation, Euro-BioImaging ERIC, FUJIFILM Holdings America Corporation, IVIM Technology Corp., KUBTEC Technology, LI-COR, Inc., Mediso Ltd., Milabs BV, Miltenyi Biotec GmbH, MR Solutions Group, Peira bvba, PerkinElmer Inc., Revvity, Inc., Scitech Pty Ltd., and United Imaging Healthcare Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Preclinical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Modalities
      • Magnetic Particle Imaging
      • Magnetic Resonance Imaging
      • Micro-Computed Tomography
      • Optical Imaging
      • Positron Emission Tomography
      • Single-Photon Emission Computed Tomography
    • Reagents
      • Bioluminescent Imaging Reagents
      • Fluorescent Imaging Reagents
      • MRI Contrasting Reagents
      • PET Radioactive Tracers
      • Ultrasound Contrasting Reagents
      • X-ray CT Contrasting Reagents
  • Application
    • Drug Discovery
    • Research & Development
  • End-User
    • Academic & Government Research Institutes
    • Contract Research Organizations (CROs)
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing research & development activities by pharmaceutical companies
5.1.1.2. Growing government investment and funding for expanding biomedical research
5.1.1.3. Rising number of clinical research organizations (CROs)
5.1.2. Restraints
5.1.2.1. High cost of imaging equipment and maintenance of preclinical imaging
5.1.3. Opportunities
5.1.3.1. Increasing incorporation of advanced technologies in preclinical imaging to improve image analysis
5.1.3.2. Rising focus on the development of personalized medicines
5.1.4. Challenges
5.1.4.1. Strict regulations and ethical concerns associated with animal research
5.2. Market Segmentation Analysis
5.2.1. Product: Growing usage of modalities in preclinical studies for specific research needs
5.2.2. End-User: Increasing adoption of preclinical imaging by pharmaceutical & biopharmaceutical companies to develop new drugs
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Preclinical Imaging Market, by Product
6.1. Introduction
6.2. Modalities
6.3. Reagents
7. Preclinical Imaging Market, by Application
7.1. Introduction
7.2. Drug Discovery
7.3. Research & Development
8. Preclinical Imaging Market, by End-User
8.1. Introduction
8.2. Academic & Government Research Institutes
8.3. Contract Research Organizations (CROs)
8.4. Pharmaceutical & Biotechnology Companies
9. Americas Preclinical Imaging Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Preclinical Imaging Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Preclinical Imaging Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Revvity, Inc.’s Innovative Preclinical Imaging Solutions Unveiled at WMIC 2023
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. PRECLINICAL IMAGING MARKET RESEARCH PROCESS
FIGURE 2. PRECLINICAL IMAGING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PRECLINICAL IMAGING MARKET DYNAMICS
FIGURE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. CANADA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. CANADA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. CANADA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 90. CANADA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 91. CANADA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 92. CANADA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 93. CANADA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. CANADA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. CANADA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. CANADA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 98. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 99. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 100. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 101. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 102. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 103. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 137. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 142. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 143. CHINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 144. CHINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 145. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 146. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 147. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. INDIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. INDIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. INDIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 154. INDIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 155. INDIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 156. INDIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 157. INDIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. INDIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. INDIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. INDIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 167. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 174. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 175. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 176. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 177. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 187. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 197. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 207. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 217. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 227. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 230. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 231. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 234. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 235. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 236. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 237. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 247. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 263. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 264. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 265. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 266. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 267. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 268. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 269. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 272. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 273. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 276. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 277. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 278. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 279. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 286. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 287. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 288. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 289. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 292. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 293. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 296. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 297. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 298. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 299. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 302. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 303. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 306. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 307. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 308. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 309. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 312. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 319. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 320. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 321. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. ITALY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 324. ITALY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 325. ITALY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 326. ITALY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 327. ITALY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 328. ITALY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 329. ITALY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. ITALY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. ITALY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 332. ITALY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 333. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 334. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 335. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 336. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 337. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 338. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 339. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 340. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 341. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 342. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 343. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 344. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 345. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2023 (USD MILLION)
TABLE 346. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2024-2030 (USD MILLION)
TABLE 347. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 348. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 349. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 350. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 351. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2

Companies Mentioned

The leading players in the Preclinical Imaging market, which are profiled in this report, include:
  • Advanced Molecular Vision, Inc.
  • Angstrom Advanced Inc.
  • Aspect Imaging Ltd.
  • Berthold Technologies
  • Bruker Corporation
  • Euro-BioImaging ERIC
  • FUJIFILM Holdings America Corporation
  • IVIM Technology Corp.
  • KUBTEC Technology
  • LI-COR, Inc.
  • Mediso Ltd.
  • Milabs BV
  • Miltenyi Biotec GmbH
  • MR Solutions Group
  • Peira bvba
  • PerkinElmer Inc.
  • Revvity, Inc.
  • Scitech Pty Ltd.
  • United Imaging Healthcare Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.48 Billion
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Reagents, Services), By Application (R&D, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Reagents, Services), By Application (R&D, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Preclinical Imaging Market Size, Share & Trends by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) - Forecast to 2029 - Product Image

Preclinical Imaging Market Size, Share & Trends by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) - Forecast to 2029

  • Report
  • 591 Pages
  • Global
From
Preclinical Imaging Global Market Report 2024 - Product Image

Preclinical Imaging Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Preclinical Imaging (In-VIVO) - Global Strategic Business Report - Product Image

Preclinical Imaging (In-VIVO) - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Optical Preclinical Imaging Market by Product Type, End-Use - Global Forecast 2025-2030 - Product Image

Optical Preclinical Imaging Market by Product Type, End-Use - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From

About the Preclinical Imaging Market

The Preclinical Imaging market is a subset of the Drug Discovery market, which focuses on the development of new drugs and treatments. Preclinical Imaging is the use of imaging technologies to study the effects of drugs on living organisms. This includes techniques such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Positron Emission Tomography (PET). These technologies allow researchers to observe the effects of drugs on the body in real-time, providing valuable insights into the efficacy and safety of potential treatments. Preclinical Imaging is used to assess the safety and efficacy of drugs before they are tested in clinical trials. Some companies in the Preclinical Imaging market include Bruker, Siemens Healthineers, Canon Medical Systems, Philips Healthcare, and GE Healthcare. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.